Google
BNTC — BENITEC BIOPHARMA LTD ADR (Healthcare >> Biotechnology)
BNTC FAQ
What is BNTC's ROE?
BENITEC BIOPHARMA LTD ADR reports a Return on Equity (ROE) of -26.66%.
What is BNTC's dividend yield?
BENITEC BIOPHARMA LTD ADR offers a dividend yield of 0.00%.
What is BNTC's Deepscope Quality Score?
Deepscope rates BNTC's overall financial quality at 38 out of 100, based on profitability, growth, debt and earnings stability.
Is now a good time to buy BNTC?
Deepscope's AI Timing Score for BNTC is 27 out of 100, indicating the relative attractiveness of buying at the current price using technical and momentum signals.
Which sector does BNTC belong to?
BENITEC BIOPHARMA LTD ADR is classified under the Healthcare >> Biotechnology sector on the NASDAQ exchange.
|
USD 10.55
Price
-0.50
(-4.52%)
Day Change
|
|
|---|
BNTC, the overall quality is not good ( Quality = 38) and the timing to buy is ...(Sign In to See)...
Loading chart...
- Signal
- UNDERPERFORM
- Signal Description
- Company financial health is Not Good
- Reason
-
ROE is relatively low.
ROA is relatively low.
Historical ROE is relatively low
ROA is too relatively low compare to ROE
Acceleration of ROA growth rate is below our criteria.
Net profit margin is relatively low.
Acceleration of net profit margin growth rate is below our criteria
Historical net profit margin is relatively low.
88 Sign in
TIMING
- Signal
- OUTPERFORM
- Signal Descri...
- Good
- Reason
- Lorem ipsum dolor sit amet
In details, quality factors are not good , financial health is not good , and ability to make profit is not good , ...
| Quality Factors |
|
42% |
| In Recommendations? | Not in any sections |
| Select Rate | 0.00 From 30 days period |
| Watch Rate | 0.00 From 30 days period |
| News Score | 93 |
| Magic Formula Rank by ROA |
N/A
|
| Magic Formula Rank by ROE |
N/A
|
| Magic Formula Rank by ROIC |
N/A
|
| Price | 10.55 |
| PBV / Sector |
1.98 / 4.63
|
| Earning Per Share | -1.42 |
| PE / Sector |
N/A / 17.43
|
| PEG or PE/Growth / Sector |
N/A / 0.53
|
| Average 1M Daily Value |
0.90 M
GREAT
|
| Average 1W Daily Value |
0.74 M
GREAT
|
| Timing Factors |
|
14% |
| Financial Health |
|
41% |
| Ability to Make Profit |
|
43% |
| Return to Investors |
|
4% |
| Registration Details |
| Analyze Date | 2026-06-06 09:08:28 |
| Symbol | BNTC |
| Name | BENITEC BIOPHARMA LTD ADR |
| Sector | Healthcare >> Biotechnology |
| Market | NASDAQ |
| Listed Shares | 34.35 M |
| Par Value | N/A |
| Calculated From | Quarter |
| Sign | N/A |
| Market Cap (M.USD) / Sector Average | 362.44 / 8,857.28 |
| News, Concensus, ... |
| Estimation Consensus | See at WSJ.com |
| Full details | See at WSJ.com |
| Chart | See in Chart feature |
| News | See at Yahoo Finance |
Address: 3940 Trust Way, Hayward, CA, United States, 94545
Phone: 510 780 0819
Website: https://benitec.com
Sector: Healthcare >> Biotechnology
Description: Benitec Biopharma Inc., a clinical-stage biotechnology company, focuses on the development of novel genetic medicines. Its Silence and Replace, a DNA-directedRNA interference platform combines RNA interference with gene therapy to create medicines that simultaneously facilitate sustained silencing of disease-causing genes and concomitant delivery of wildtype replacement genes following a single administration of the therapeutic construct. The company is developing BB-301, an AAV-based gene therapy designed to silence the expression of the disease-causing gene for the treatment of oculopharyngeal muscular dystrophy related dysphagia. Benitec Biopharma Inc. is headquartered in Hayward, California.
ME vs SECTOR Healthcare >> Biotechnology
Click a bubble to view stock details · Bubble size represents market capitalization share
